Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asian Phytoceuticals PCLBKK:APCO-R 62 Net Cash per Share is ฿0.52 as of Mar. 2026, which is 100% below its 10-year median of 11.10. GuruFocus rates BKK:APCO-R with a GF Score™ of 62/100 and a GF Value™ of ฿7.41. The stock has 4 warning signs investors should review. Among 348 Consumer Packaged Goods companies, Asian Phytoceuticals PCL ranks better than 65.8% on this metric.
The historical rank and industry rank for Asian Phytoceuticals PCL's Net Cash per Share or its related term are showing as below:
BKK:APCO-R'
s Price-to-Net-Cash Range Over the Past 10 Years
Min: 4.3 Med: 11.1 Max: 57
Current: 5.02
During the past 13 years, the highest Price-to-Net-Cash Ratio of Asian Phytoceuticals PCL was 57.00. The lowest was 4.30. And the median was 11.10.
BKK:APCO-R's Price-to-Net-Cash is ranked better than 65.8% of 348
companies
in the Consumer Packaged Goods industry
Industry Median: 8.635
vs BKK:APCO-R: 5.02
Asian Phytoceuticals PCL (BKK:APCO-R) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
Asian Phytoceuticals PCL Net Cash per Share Related Terms
Asian Phytoceuticals PCL Net Cash per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:APCO-R vs PG, CL, KVUE: Net Cash per Share Comparison
For the Household & Personal Products subindustry, Asian Phytoceuticals PCL's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asian Phytoceuticals PCL Price-to-Net-Cash vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Asian Phytoceuticals PCL's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where Asian Phytoceuticals PCL's Price-to-Net-Cash falls into.
Asian Phytoceuticals PCL Net Cash per Share Calculation
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
Asian Phytoceuticals PCL's Net Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asian Phytoceuticals PCL (BKK:APCO-R) has a Net Cash per Share of ฿0.52 as of Mar. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Asian Phytoceuticals PCL and its competitors. This is 95% below median its historical median of 11.10. Over the past decade, Asian Phytoceuticals PCL's Net Cash per Share has ranged from 4.30 to 57.00. According to the industry distribution chart, Asian Phytoceuticals PCL ranks #119 out of 348 companies in the Consumer Packaged Goods industry, placing it in the top 34.2%.
Is Asian Phytoceuticals PCL's Net Cash per Share too high?
Asian Phytoceuticals PCL's current Net Cash per Share of ฿0.52 is 95% below median its 10-year median of 11.10. Over the past 10 years, this metric has ranged from a low of 4.30 to a high of 57.00. Based on the distribution chart, Asian Phytoceuticals PCL ranks #119 out of 348 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Asian Phytoceuticals PCL has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Asian Phytoceuticals PCL's Net Cash per Share compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Asian Phytoceuticals PCL ranks #119 out of 348 companies for Net Cash per Share. This puts Asian Phytoceuticals PCL in the upper half of its industry. The industry median Net Cash per Share is 8.64. Historically, Asian Phytoceuticals PCL's own Net Cash per Share has ranged from 4.30 to 57.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Consumer Packaged Goods company?
The median Net Cash per Share among Consumer Packaged Goods companies is 8.64, based on 348 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Asian Phytoceuticals PCL and its competitors. For the Consumer Packaged Goods industry, the median Net Cash per Share is 8.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asian Phytoceuticals PCL's current Net Cash per Share is ฿0.52, which is 95% below median its own 10-year median of 11.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asian Phytoceuticals PCL stock overvalued right now?
Asian Phytoceuticals PCL (BKK:APCO-R) has a current Net Cash per Share of ฿0.52. The stock's GF Value™ is ฿7.41, compared to a current price of ฿6.27 — trading 15.3% below its estimated fair value. The current Net Cash per Share is ฿0.52, which is 95% below median its 10-year median of 11.10. Asian Phytoceuticals PCL's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For Asian Phytoceuticals PCL (BKK:APCO-R), the current Net Cash per Share is ฿0.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asian Phytoceuticals PCL (BKK:APCO-R) Overvalued in 2026?
Based on GuruFocus' analysis, Asian Phytoceuticals PCL stock appears to be undervalued.
The current stock price of ฿6.27 is trading 15.3% below its estimated GF Value™ of ฿7.41.
Key valuation signals for BKK:APCO-R:
Net Cash per Share: ฿0.52 (95% below median its 10-year median of 11.10)
GF Value™: ฿7.41 vs. price of ฿6.27 (15.3% below fair value)
No single metric tells the full story. See the BKK:APCO-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asian Phytoceuticals PCL engages in the manufacturing and marketing of herbal healthcare products. The company engages in the production and distribution of dietary supplements, cosmetics, and personal care products made from natural herbs. Its beauty products include skin nourishing and skin care products, hair loss treatment and hair growth products, slimming products, dietary supplements, and other nutritional products. Geographically, the company offers its services only in Thailand.
62GF Score
Get the complete analysis for BKK:APCO-R
Net Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:APCO-R has been successfully added to your 
